Predictive Value of Systemic Inflammatory Indices in Drug Hypersensitivity Severity
International Archives of Allergy and Immunology · 11.06.2026 · 1-8
DOI: 10.1159/000552668 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Archives of Allergy and Immunology, online erschienen am 11.06.2026. Verfasst von Aysu Okumuş Güçlü und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology and Allergy, İzmir City Hospital, İzmir, Turkey, aysuokumus@gmail.com. Die Arbeit nennt 14 Literaturangaben.
Abstract (Originalsprache)
Introduction
Drug hypersensitivity reactions (DHRs) range from mild cutaneous symptoms to life-threatening anaphylaxis, necessitating practical biomarkers for severity prediction and risk stratification. This study aimed to evaluate the predictive value of Systemic Immune-Inflammation Index (SII), Systemic Inflammation Response Index (SIRI), and Aggregate Index of Systemic Inflammation (AISI) measured during a stable period in patients with drug allergy.
Methods
This study included 200 patients with DHRs, categorized into severe (anaphylaxis; n = 67) and non-severe (n = 133) groups. To reflect steady-state inflammatory status, hemogram parameters were obtained at least 1 month after resolution of acute symptoms. Diagnostic performances were assessed using age- and sex-adjusted logistic regression and ROC analysis.
Results
Baseline SII, SIRI, and AISI were all significantly higher in the severe group (SII: 516.8 vs. 438.1, p = 0.009; SIRI: 1.08 vs. 0.88, p = 0.012; AISI: 286.6 vs. 221.9, p = 0.001). In age- and sex-adjusted models, each index independently predicted anaphylaxis per 1-SD increase: SII OR 1.55 (95% CI 1.13–2.20), AISI OR 1.50 (95% CI 1.12–2.06), and SIRI OR 1.45 (95% CI 1.08–1.97). Using Youden-optimized thresholds, AISI ≥197 yielded the highest adjusted odds of anaphylaxis (aOR 4.11, 95% CI 2.00–9.07; p < 0.001), followed by SII ≥333 (aOR 3.56, 95% CI 1.55–9.28; p = 0.005) and SIRI ≥1.37 (aOR 3.11, 95% CI 1.59–6.15; p < 0.001).
Conclusion
Systemic inflammatory indices are independently associated with reaction severity in patients with immediate-type drug hypersensitivity. With AUC values ranging from 0.61 to 0.64, these indices demonstrate modest discriminatory performance and should be regarded as adjunctive screening tools rather than standalone diagnostic markers. Their elevation during the stable period may reflect a chronic pro-inflammatory state that predisposes individuals to more severe reactions upon drug exposure, a hypothesis requiring prospective validation in larger, multicenter cohorts.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Immunology and Allergy, İzmir City Hospital, İzmir, Turkey, aysuokumus@gmail.com.
- Department of Immunology and Allergy, İzmir City Hospital, İzmir, Turkey.
Zitieren
APA
Okumuş Güçlü, A., Seren, O. T., Özaydın Ünal, S. E., Kocabaş, M. E., Aksu, B., Özmen, Ü., Hafızoğlu, M., & Bayrak Değirmenci, P. (2026). Predictive Value of Systemic Inflammatory Indices in Drug Hypersensitivity Severity. International Archives of Allergy and Immunology, 1-8. https://doi.org/10.1159/000552668
Vancouver
Okumuş Güçlü A, Seren OT, Özaydın Ünal SE, Kocabaş ME, Aksu B, Özmen Ü, et al. Predictive Value of Systemic Inflammatory Indices in Drug Hypersensitivity Severity. International Archives of Allergy and Immunology. 2026:1-8. doi:10.1159/000552668
BibTeX
@article{OkumuGl2026,
author = {Okumuş Güçlü, Aysu and Seren, Orbay Tutku and Özaydın Ünal, Sultan Ece and Kocabaş, Mehmet Emin and Aksu, Betül and Özmen, Ümit and Hafızoğlu, Mehtap and Bayrak Değirmenci, Papatya},
title = {Predictive Value of Systemic Inflammatory Indices in Drug Hypersensitivity Severity},
journal = {International Archives of Allergy and Immunology},
year = {2026},
pages = {1--8},
doi = {10.1159/000552668}
}
EUVIMED